AbbVie
NYSE: ABBV
$256.46
as on
AbbVie Stock Performance
as on September 5, 2026 at 2:16 pm IST
Day's Low
Day's High
$255.61$258.91
0.33%
Downside
0.96%
Upside
52 Week's Low
52 Week's High
$190.75$267.4725.62%
Downside
4.29%
Upside
AbbVie share price movements today
- Previous Close
- $260.21
- Open
- $258.30
- Volume
- 2.6M
- Market Cap
- $459.4B
- Dividend Yield
- 2.72%
- Day's Low - High
- $255.61 - $258.91
- 52 Week Low - High
- $190.75 - $267.47
AbbVie Historical Returns
- 1 Month Return
- + 6.73 %
- 3 Month Return
- + 15.68 %
- 1 Year Return
- + 22.16 %
- 3 Year Return
- + 75.58 %
- 5 Year Return
- + 133.12 %
AbbVie Stock Fundamentals & Key Indicators
Check AbbVie market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$459.4B
EPS (TTM)
3.55
Dividend Yield
2.72%
Quarterly Earnings Growth YOY
2.90%
PE Ratio (TTM)
70.68
Industry PE ratio
22.90
PEG Ratio
1.035663865020112
EBITDA
21.2B
Revenue (TTM)
64.4B
Profit Margin
71.48%
Return On Equity TTM
-136.50%
AbbVie Stock Valuation
Track how AbbVie P/E has moved over time to understand its valuation trends.
AbbVie in the last 5 years
Lowest (20.76x)
December 31, 2021
Industry (22.90x)
December 31, 2025
Today (96.41x)
December 31, 2025
Highest (96.41x)
December 31, 2025
Today’s Price to Earnings Ratio: 96.41x
AbbVie vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of AbbVie with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $459.4B | 133.12% | 70.68 | 71.48% | 2.7199999999999998% | |
| BUY | $1.1T | 346.81% | 38.84 | 84.01% | 0.58% | |
| BUY | $653.5B | 59.07% | 32.19 | 70.45% | 1.9% | |
| BUY | $369.7B | 97.18% | 120.35 | 4.77% | 221.58% | |
| BUY | $250.2B | 40.04% | 24.34 | 17.02% | 129.31% |
Stock Returns calculator for AbbVie Stock including INR - Dollar returns
The AbbVie stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
AbbVie investment value today
Current value as on today
₹1,29,010
Returns
₹29,010
(+29.01%)
Returns from AbbVie Stock
₹20,404 (+20.4%)
Dollar Impact
₹8,606 (+8.61%)
Analyst Recommendation on AbbVie Stock
Based on 23 analysts
82.61%
Buy
17.39%
Hold
0.00%
Sell
Based on 23 analysts, 82.6086956521739% of analysts recommend a 'BUY' rating for AbbVie. Average target price of $276.59
AbbVie Share Price Target
Get share price movements and forecasts by analysts on AbbVie.
What analysts predicted
7.28%UPSIDE
Target Price
$276.59
Current Price
$256.46
Analyzed by
23 Analysts
Target
$276.59
AbbVie target price $276.59, a slight upside of 7.28% compared to current price of $256.46. According to 23 analysts rating.
Indian Investors' Interest in AbbVie Stock
Investment in AbbVie Shares on INDmoney has dropped by -13.50% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for AbbVie Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4%Â versus previous 30 day period
AbbVie Quarterly Profit & Loss
All numbers in Millions USD
AbbVie Annual Profit & Loss
All numbers in Millions USD
AbbVie Quarterly Cash Flow
All numbers in Millions USD
AbbVie Annual Cash Flow
All numbers in Millions USD
AbbVie News & Key Events
Today's Timeline - 04 September
Fri, 01:49 PM
-AbbVie reports positive Phase 3 results for etentamig in multiple myeloma, outperforming standard therapies with strong efficacy.
Fri, 07:29 PM
-AbbVie boosts quarterly dividend by 5.5% to $1.73 despite Humira sales decline, supported by strong free cash flow.
Fri, 08:18 PM
-AbbVie reports positive top-line data from Phase III CERVINO study for etentamig in relapsed/refractory multiple myeloma.
Today's Timeline - 04 September
Fri, 09:00 PM
-AbbVie reports $16.99 billion revenue, EPS of $3.65, and forecasts $3.86 EPS for the current quarter.
Insights on AbbVie
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
AbbVie Inc. has shown positive revenue growth over the last two quarters. In the most recent quarter, the revenue increased from $15.00 billion to $16.99 billion, reflecting an average growth rate of 11.7% per quarter.
- POSITIVE IMPACT
Profit Spike
AbbVie Inc. has shown strong profit growth over the last two quarters. In the most recent quarter, the company's net profit increased significantly from $699 million to $3.61 billion. This represents an average growth rate of 80.7% per quarter.
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ABBV has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 1 month, ABBV stock has moved up by 5.2%
NO EFFECTAgainst Peers
In the last 1 year, Merck & Co., Inc. has given 77.5% return, outperforming this stock by 56.8%
About AbbVie
| Organisation | AbbVie |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of AbbVie
Name | Title |
|---|---|
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Linda Ray | Senior VP & Chief Information Officer |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki Ph.D. | Executive VP & COO |
Dr. Roopal B. Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
FAQs
What is AbbVie share price today?
AbbVie share price today is $256.46 as on at the close of the market. AbbVie share today touched a day high of $258.91 and a low of $255.61.
What is the 52 week high and 52 week low for AbbVie share?
AbbVie share touched a 52 week high of $267.47 on and a 52 week low of $190.75 on . AbbVie stock price today i.e. is closed at $256.46,which is 4.12% down from its 52 week high and 34.45% up from its 52 week low.
What is AbbVie's market capitalisation today?
AbbVie market capitalisation is $0.46T as on .
How to invest in AbbVie Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for AbbVie on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AbbVie Shares that will get you 0.0058 shares as per AbbVie share price of $256.46 per share as on September 5, 2026 at 8:46 am IST.
What is the minimum amount required to buy AbbVie Stock (ABBV) from India?
Indian investors can start investing in AbbVie (ABBV) shares with as little as ₹94.49 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.90 in AbbVie stock (as per the Rupee-Dollar exchange rate as on ).
Based on AbbVie share’s latest price of $256.46 as on September 5, 2026 at 8:46 am IST, you will get 0.0390 shares of AbbVie. Learn more about
fractional shares .
What are the returns that AbbVie has given to Indian investors in the last 5 years?
AbbVie stock has given 133.12% share price returns and 29.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?